Volume 16 Issue 10
Aug.  2022
Turn off MathJax
Article Contents
ZHAO Rui, WANG Qi-zhi, ZHENG Hai-lun. Serum levels of Golgi protein 73 before and after TACE in patients with primary liver cancer and its clinical significance[J]. Chinese Journal of General Practice, 2018, 16(10): 1623-1625. doi: 10.16766/j.cnki.issn.1674-4152.000441
Citation: ZHAO Rui, WANG Qi-zhi, ZHENG Hai-lun. Serum levels of Golgi protein 73 before and after TACE in patients with primary liver cancer and its clinical significance[J]. Chinese Journal of General Practice, 2018, 16(10): 1623-1625. doi: 10.16766/j.cnki.issn.1674-4152.000441

Serum levels of Golgi protein 73 before and after TACE in patients with primary liver cancer and its clinical significance

doi: 10.16766/j.cnki.issn.1674-4152.000441
  • Received Date: 2017-12-22
    Available Online: 2022-08-06
  • Objective To explore the clinical significance of serum Golgi protein 73 (GP73) levels before and after transcatheter arterial chemoembolization (TACE) in patients with primary hepatocellular carcinoma (PHC), and discuss the role of GP73 in the curative effect evaluation and prognosis monitoring among the PHC patients undergoing TRAC. Methods The Enzyme-link immunosorbent assay (ELISA) was used to detect the serum levels of GP73 and AFP in 40 cases of HPC before TACE, D1 after TRAC and 4 to 6 weeks after TACE. Based on the result of TRAC, 40 patients were assigned into the improved group(28 cases) and progression group (12 cases). The relationship between the dynamic levels of GP73 and AFP and the curative effect and prognosis of the patients were analyzed. Results In the improved group, the serum GP73 level before TACE, on the first day and in four to six weeks after TACE were (0.390±0.161) IU/ml, (0.385±0.165) IU/ml and (0.187±0.125) IU/ml, respectively. The serum GP73 level on the first day after TRAC were not significantly improved(P>0.05), however, in the four to six weeks after TRAC it decreased significantly as compared with the preoperative levels (P<0.05). In the progression group, the serum GP73 level before TACE, on the first day after TACE and in the four to six weeks after TACE were (0.373±0.134) IU/ml, (0.372±0.130) IU/ml and (0.604±0.121) IU/ml, respectively. The serum GP73 level did not change significantly on the first day after TRAC(P>0.05), however, it elevated significantly in the four to six weeks after TACE (P<0.05). For the HPC patients with AFP level less than 400 ng/ml, the serum GP73 level in the four to six weeks after TACE significantly decreased in the improved group (P<0.05), but significantly increased in the progression group (P<0.05); however, the AFP level did not change significantly before and after TACE (P>0.05). Conclusion The serum GP73 could be taken as an effective indicator in monitoring the therapeutic effect of TACE in patients with PHC. The GP73 has more advantages than AFP in the monitoring the therapeutic effect of TACE while the serum AFP level is less than 400 ng/ml.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (198) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return